UK researchers have said that a new combination of chemotherapy drugs is offering new hope to cancer patients; it is set to become the main therapy for pancreatic cancer as the disease is so hard to treat. Survival rates have barely changed over the decades.

The Data presented at the World’s biggest cancer conference has shown long-term survivals could be increased from 16 percent to 29 percent.

No Comments

Leave a Comment